C2C12 AAV Muscular dystrophy Nuclear envelope Cancer biomarkers Laminopathies AAV VECTOR Maladies rares et orphelines GNE CSF protein Hypermobile EDS Maladies rares Heart Regeneration Emery-Dreifuss muscular dystrophy Errance diagnostique Rare neuromuscular diseases Biological sciences Lamin A/C Actionable gene COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders LMNA-related congenital muscular dystrophy LMNA gene Connective tissue Butyrylcholinesterase Titin Cancer Heart failure Allele-specific silencing therapy Lamin A/C LMNA gene INPP5K Dynamin 2 BVES Lamins BiP Therapy Patient registry CMTX Centronuclear myopathy Gene therapy Cardiomyopathy Next generation sequencing Myogenesis Cardiology A-type lamin Duchenne muscular dystrophy Biomarker CRISPR Rare diseases Calcium handling Cardiac conduction system Emerin Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS LMNA Laminopathie Myotubes POPDC1 Muscle biopsy Dilated cardiomyopathy Lamin A/C nuclei Exome Acetyltransferase IPSC C elegans Adult SMA Congenital muscular dystrophy Myologie Clinical trial Mouse Muscular dystrophy MD COVID-19 Treatment delay Dystrophie musculaire Myopathy Myopathies LGMD Skeletal muscle Laminopathy A-type lamins Allele-specific silencing Treatment Mutations RNA interference Angiotensin-converting enzyme inhibitor Allele‐specific silencing therapy Autophagosome maturation Becker muscular dystrophy Neuromuscular diseases Actionability Joint laxity Muscle MRI Ehlers‐Danlos Syndrome Diagnosis COL1A1 COL6A1 Muscle Angiotensin-converting enzyme inhibitors Dystrophine Base de données FAIR Alternative splicing